Ellipse Pharmaceuticals

Ellipse Pharmaceuticals is a French contract research and development organization (CRDO) specializing in the formulation and development of complex drug products. The company focuses on improving the bioavailability and stability of poorly soluble active pharmaceutical ingredients (APIs) using advanced lipid-based delivery systems. Their core expertise includes technologies such as Self-Emulsifying Drug Delivery Systems (SEDDS) and Self-Microemulsifying Drug Delivery Systems (SMEDDS). Ellipse provides a comprehensive range of services from early-stage pre-formulation and analytical development to the production of GMP clinical batches. The company operates a state-of-the-art facility in Martillac, France, equipped for Phase I and Phase II clinical trial material manufacturing.